查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1467888

2024-2032 年女性健康診斷市場報告（按類型、應用、最終用戶和地區）

Women's Health Diagnostics Market Report by Type, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球女性健康診斷市場規模達到292億美元。

女性健康診斷有助於診斷女性患者的各種生物和社會心理狀況。它們有助於解決性和陰道問題以及懷孕併發症，並控制威脅疾病，例如骨質疏鬆症、更年期以及某些癌症（如乳癌和子宮頸癌）。他們依賴一系列先進的實驗室測試、工具和程序，包括活體組織切片、超音波、化療和磁振造影 (MRI)。一些醫療保健診斷中心目前正在提供廣泛的實驗室檢測解決方案，以加強對影響女性的罕見疾病和病症的診斷和管理。

女性健康診斷市場趨勢：

影響女性整體福祉的健康問題日益普遍，是對市場產生正面影響的主要因素之一。此外，健康意識的增強以及對早期診斷益處的認知不斷增強，正在推動全球對即時護理 (POC) 女性健康診斷的需求。除此之外，由於生活方式的壓力以及酒精和毒品消費的增加，不孕率不斷上升，這推動了對婦女健康診斷的需求，以解決妊娠併發症並確保更健康的生活。此外，由於更年期會增加某些疾病的風險，包括心血管疾病和尿失禁，因此50歲以上女性人口的顯著增加也促進了市場的成長。除此之外，多項研究得出的結論是，女性在荷爾蒙變化期間更容易出現精神疾病，例如憂鬱和焦慮。這與許多國家的衛生機構為改善婦女心理健康而採取的多項措施相結合，正在推動全球市場的成長。

本報告回答的關鍵問題

  • 2023年全球女性健康診斷市場規模有多大？
  • 2024-2032年全球女性健康診斷市場的預期成長率是多少？
  • 推動全球女性健康診斷市場的關鍵因素是什麼？
  • COVID-19 對全球女性健康診斷市場有何影響？
  • 全球女性健康診斷市場按類型分類是怎樣的？
  • 基於應用的全球女性健康診斷市場的細分如何？
  • 基於最終用戶的全球女性健康診斷市場的詳細情形如何？
  • 全球女性健康診斷市場的重點區域有哪些？
  • 全球女性健康診斷市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球女性健康診斷市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按類型

  • 診斷設備
    • 市場走向
    • 關鍵環節
      • 切片裝置
      • 影像和監測設備
      • 配件及消耗品
    • 市場預測
  • 診斷測試
    • 市場走向
    • 關鍵環節
      • 乳癌檢測
      • 子宮頸抹片檢查和 HPV 檢測
      • 懷孕測試和排卵測試
      • 其他
    • 市場預測

第 7 章：市場區隔：按應用

  • 乳癌
    • 市場走向
    • 市場預測
  • 傳染病檢測
    • 市場走向
    • 市場預測
  • 骨質疏鬆症測試
    • 市場走向
    • 市場預測
  • 懷孕和生育力測試
    • 市場走向
    • 市場預測
  • 性傳染病檢測
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依最終用戶

  • 醫院和診斷中心
    • 市場走向
    • 市場預測
  • 居家護理
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Becton Dickinson and Company
    • bioMerieux SA
    • Cardinal Health Inc.
    • Cook Group Incorporated
    • F. Hoffmann-La Roche AG
    • General Electric Company
    • Hologic Inc.
    • Koninklijke Philips NV
    • Perkinelmer Inc.
    • Quest Diagnostics Inc.
    • Siemens AG
    • Thermo Fisher Scientific Inc.
Product Code: SR112024A4956

The global women's health diagnostics market size reached US$ 29.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 52.6 Billion by 2032, exhibiting a growth rate (CAGR) of 6.6% during 2024-2032.

Women's health diagnostics help diagnose various biological and psychosocial conditions of female patients. They assist in addressing sexual and vaginal issues and pregnancy complications and managing threatening diseases, such as osteoporosis, menopause, and certain cancers like breast and cervical. They rely on a series of advanced laboratory tests, tools, and procedures, which include biopsy, ultrasound, chemotherapy, and magnetic resonance imaging (MRI). Several healthcare diagnostics centers are currently offering an expansive range of laboratory testing solutions to enhance the diagnosis and management of rare diseases and conditions that affect women.

Women's Health Diagnostics Market Trends:

The rising prevalence of health issues that impact the overall well-being of women represents one of the major factors influencing the market positively. Moreover, the growing health consciousness, along with the increasing awareness about the benefits of early diagnosis, is catalyzing the demand for point-of-care (POC) women's health diagnostics across the globe. Apart from this, the rising rate of infertility on account of stressful lifestyles and the growing consumption of alcohol and drugs is driving the need for women's health diagnostics to address pregnancy complications and ensure a healthier life. Furthermore, as menopause can increase the risk of developing certain medical conditions, including cardiovascular diseases and urinary incontinence, a significant rise in the female population which is over 50 years is contributing to the market growth. Besides this, several research studies have concluded that women are more likely to experience psychiatric disorders, such as depression and anxiety, during hormonal changes. This, in confluence with several initiatives undertaken by health agencies of numerous countries to improve mental health of women, is propelling the market growth across the globe.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global women's health diagnostics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, application, and end user.

Breakup by Type:

Diagnostic Devices

Biopsy Device

Imaging and Monitoring Devices

Accessories and Consumables

Diagnostic Tests

Breast Cancer Testing

PAP Smear and HPV Test

Pregnancy Testing and Ovulation Testing

Others

Breakup by Application:

Breast Cancer

Infectious Disease Testing

Osteoporosis Testing

Pregnancy and Fertility Testing

Sexually Transmitted Disease Testing

Others

Breakup by End User:

Hospital and Diagnostics Centers

Home Care

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, bioMerieux SA, Cardinal Health Inc., Cook Group Incorporated, F. Hoffmann-La Roche AG, General Electric Company, Hologic Inc., Koninklijke Philips N.V., Perkinelmer Inc., Quest Diagnostics Inc., Siemens AG and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global women's health diagnostics market in 2023?
  • 2. What is the expected growth rate of the global women's health diagnostics market during 2024-2032?
  • 3. What are the key factors driving the global women's health diagnostics market?
  • 4. What has been the impact of COVID-19 on the global women's health diagnostics market?
  • 5. What is the breakup of the global women's health diagnostics market based on the type?
  • 6. What is the breakup of the global women's health diagnostics market based on the application?
  • 7. What is the breakup of the global women's health diagnostics market based on the end user?
  • 8. What are the key regions in the global women's health diagnostics market?
  • 9. Who are the key players/companies in the global women's health diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Women's Health Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Diagnostic Devices
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Biopsy Device
      • 6.1.2.2 Imaging and Monitoring Devices
      • 6.1.2.3 Accessories and Consumables
    • 6.1.3 Market Forecast
  • 6.2 Diagnostic Tests
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Breast Cancer Testing
      • 6.2.2.2 PAP Smear and HPV Test
      • 6.2.2.3 Pregnancy Testing and Ovulation Testing
      • 6.2.2.4 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Breast Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Infectious Disease Testing
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Osteoporosis Testing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Pregnancy and Fertility Testing
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Sexually Transmitted Disease Testing
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospital and Diagnostics Centers
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Home Care
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 bioMerieux SA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Cardinal Health Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Cook Group Incorporated
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 F. Hoffmann-La Roche AG
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 General Electric Company
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Hologic Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Koninklijke Philips N.V.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Perkinelmer Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Quest Diagnostics Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Siemens AG
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13 Thermo Fisher Scientific Inc.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Women's Health Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Women's Health Diagnostics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Women's Health Diagnostics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Women's Health Diagnostics Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Women's Health Diagnostics Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Women's Health Diagnostics Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Women's Health Diagnostics Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Women's Health Diagnostics (Diagnostic Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Women's Health Diagnostics (Diagnostic Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Women's Health Diagnostics (Diagnostic Tests) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Women's Health Diagnostics (Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Women's Health Diagnostics (Breast Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Women's Health Diagnostics (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Women's Health Diagnostics (Infectious Disease Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Women's Health Diagnostics (Infectious Disease Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Women's Health Diagnostics (Osteoporosis Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Women's Health Diagnostics (Osteoporosis Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Women's Health Diagnostics (Pregnancy and Fertility Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Women's Health Diagnostics (Pregnancy and Fertility Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Women's Health Diagnostics (Sexually Transmitted Disease Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Women's Health Diagnostics (Sexually Transmitted Disease Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Women's Health Diagnostics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Women's Health Diagnostics (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Women's Health Diagnostics (Hospital and Diagnostics Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Women's Health Diagnostics (Hospital and Diagnostics Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Women's Health Diagnostics (Home Care) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Women's Health Diagnostics (Home Care) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: North America: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: North America: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: United States: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: United States: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Canada: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Canada: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Asia-Pacific: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Asia-Pacific: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: China: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: China: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Japan: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Japan: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: India: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: India: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: South Korea: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: South Korea: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Australia: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Australia: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Indonesia: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Indonesia: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Others: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Others: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Europe: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Europe: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Germany: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Germany: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: France: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: France: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: United Kingdom: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: United Kingdom: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Italy: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Italy: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Spain: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Spain: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Russia: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Russia: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Others: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Others: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Latin America: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Latin America: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Brazil: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Brazil: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Mexico: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Mexico: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Middle East and Africa: Women's Health Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Middle East and Africa: Women's Health Diagnostics Market: Breakup by Country (in %), 2023
  • Figure 76: Middle East and Africa: Women's Health Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Global: Women's Health Diagnostics Industry: SWOT Analysis
  • Figure 78: Global: Women's Health Diagnostics Industry: Value Chain Analysis
  • Figure 79: Global: Women's Health Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Women's Health Diagnostics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Women's Health Diagnostics Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Women's Health Diagnostics Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Women's Health Diagnostics Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Women's Health Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Women's Health Diagnostics Market: Competitive Structure
  • Table 7: Global: Women's Health Diagnostics Market: Key Players